Navigation Links
Bird Flu Virus Can Infect Fetus
Date:9/28/2007

H5N1 also migrates to organs other than lungs, autopsy study shows

FRIDAY, Sept. 28 (HealthDay News) -- The deadly H5N1 bird flu virus can pass through the placenta of pregnant women and into the fetus, Chinese scientists report.

They also discovered that the virus infects organs other than lungs in adults.

The researchers, from Peking University in Beijing, analyzed tissue samples taken from two people -- a man and a pregnant women -- killed by bird flu, to determine how the virus affects different body organs.

They detected H5N1 genetic material and antigens in the lungs, certain cells in the trachea, the T-cells of the lymph node, neurons in the brain, and in cells of the placenta. They also found H5N1 genetic material in the intestinal mucosa but did not find any antigens there.

The dead woman's fetus had H5N1 genetic material and antigens in the lungs, circulating cells of the immune system, and in cells of the liver.

The findings are published in this week's issue of The Lancet medical journal.

"This study has shown the capacity for human vertical transmission of the H5N1 virus" and this "warrants careful investigation, since maternal infections with common human influenza virus are generally thought not to infect the fetus," the researchers wrote.

This and the finding that H5N1 spreads beyond the lungs in adults "are important in the clinical, pathological and epidemiological investigation of human H5N1 infection, and have implications for public health and health care providers."

More information

The World Health Organization has more about bird flu.



-- Robert Preidt



SOURCE: The Lancet, news release, Sept. 27, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Ebola Virus - Outbreak Claims More Lives In Uganda.
3. Experimental treatment for Ebola Virus Shows promising results in mice
4. Virus Combats Brain Tumour
5. Virus killer
6. Minor mutations in HIV virus
7. Virus makes Hodgkin’s disease more deadl
8. Infertility in relation with virus
9. Birds breed viruses
10. Hidden influenza virus protein found
11. Pain Killers Keep the Virus Away
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...aby acne needs no treatment. Infants aging a few d...rown 2 months. It appears as red or white bumps/s... hormonal changes inside the growing infant. // Ba... the face and chest. Yale-New Haven Hospital, rec...
...: Millions of Indians are being exposed to high le...volatile organic compounds and sulphur fumes//, an...gulate these toxins, according to a report relased...ent Air Quality in India,' the report by the Chenn...
... to new US recommendations one should decrease cho... other beneficial functions of cholesterol//. Aggr...or affected groups to the tune of LDL-cholesterol ...1 millimoles per litre of blood (mmol/l) in high-r...
...rs can now perform gene mapping, ten times faster ...me of linked computers// and unwind the mysteries ...the study, conducted by researchers from Technion-...n published in the American Journal of Human Genet...
Other Medicine News:Health News:Sleeping Computers Yield Clues About Genetic Disorders 2
(Date:10/6/2008)... Improve Patient Safety, WASHINGTON, Oct. 6 /PRNe...iology in collaboration with the American College ...tion today released consensus guidelines,outlining...rs and,gastrointestinal (GI) bleeding among patien...IDs) along with antiplatelet agents., Gastrointes...
(Date:10/6/2008)... Dosed Prior to Surgery, TAMPA, Fla., Oct. 6 /PRN... held ophthalmic-focused biopharmaceutical company...ophthalmic emulsion) 0.05% is now,commercially ava...od and,Drug Administration in June 2008, is a topi...eatment of inflammation and pain associated with o...
(Date:10/6/2008)...irstCall/ -- Genaera,Corporation (Nasdaq: GENR ) ...al trial of trodusquemine (MSI-1436), Genaera,s le...etes and obesity. MSI-1436 is a novel,inhibitor of... the function,of both the leptin and insulin pathw... the study, MSI-1436 was found to be well-tolerate...
(Date:10/6/2008)...patients achieved endoscopic,response and more tha... 10,in data from a 54-week open-label study presen...CG) Annual Scientific Meeting, ORLANDO, Fla., Oct...a,large, prospective study investigating endoscopi...gic compound. The data presented at the American,C...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Industry Executives Finding Value in Shift of Scientific Publications 5484 1Industry Executives Finding Value in Shift of Scientific Publications 5484 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 1Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 3Researchers expand natural killer cells in cord blood to fight leukemia 19605 1Researchers expand natural killer cells in cord blood to fight leukemia 19605 2New drug combination brings 1 2 punch against acute leukemia 19604 1New drug combination brings 1 2 punch against acute leukemia 19604 2
...13, 2007, 2007, SAN DIEGO, and SEOUL, South Korea,...euticals, Inc. and LG Life,Sciences, Ltd., present... (LB80380) retains potency against multiple mutant...stant to lamivudine,adefovir, entecavir or telbiv...nual Meeting of the European Association for the S...
...c Hepatitis B e-Antigen,(HBeAg)-Negative Patients ...Treatment, PRINCETON, N.J., April 13, 2007 /PRNews...day announced data from a cohort of,nucleoside-nai...V-027/901, n=99). These data showed that patients ...rus in the blood,after interruption of treatment w...
Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours.
Medicine Products: